Thermo Fisher Scientific

© Getty Images

Verici Dx receives boost with Thermo Fisher licensing deal

By Isabel Cameron

Verici Dx, a company developing advanced clinical diagnostics for organ transplant, has entered into a global licensing partnership with healthcare giant Thermo Fisher to develop an assay for pre-transplant kidney testing.

© GettyImages/courtneyk

Thermo Fisher opens Swiss biologics production facility

By Jane Byrne

The operation of the 1.5 million square-foot biologics manufacturing site in Lengnau, Switzerland is part of a strategic partnership agreed with CSL Limited, announced last year, says Thermo Fisher Scientific.

© GettyImages/FlashMovie

NPD Gallery: Technology Insider

By Jane Byrne

We report on some of the latest biopharma industry targeted new releases in terms of technological innovation.

(Image: Getty/BrianAJackson)

July roundup sees flurry of partnership deals

By Ben Hargreaves

The summer months are traditionally slow on movements across the industry, but July saw a number of manufacturing partnership deals take place as companies look ahead to product commercialization.

Five biggest CDMO deals of the year

Five deals reshaping the CDMO industry this year

By Ben Hargreaves

The major trend so far in 2019 is the willingness to deploy capital to expand services in the cell and gene therapy sector, and we outline the five most significant deals thus far.

Cobra Biologics moves to beef up mAb capacity

Cobra Biologics moves to beef up mAb capacity

By Gareth Macdonald

Corba Biologics has opted for a HyClone bioreactor to boost its antibody production capacity citing customer demand and biosimilars as the drivers for the investment.

Industry News in Brief

Industry News in Brief

By Dr Matt Wilkinson

A round up of recent industry news from Abbott Laboratories,
Bio-Rad, Horiba, MDS Nordion, Nimblegen, Roche Diagnostics and
Thermo Fisher Scientific.